法瓦瑞斯制药 PHVS
$34.39 +$1.86 (+5.72%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $35.00 +1.77%
开盘$32.85
昨收$32.53
当日区间$32.28 – $35.21
成交量405.1K
市值$2.41B
市盈率（TTM）–
股息率–
PHVS 相关新闻
匹配 Pharvaris 或代码 PHVS 的头条新闻，按最新排序。
- Morgan Stanley Maintains Pharvaris(PHVS.US) With Buy Rating, Maintains Target Price $46
- Form 144(Amend) | Pharvaris(PHVS.US) Officer Proposes to Sell 7 Million in Common Stocks
- H.C. Wainwright Maintains Pharvaris(PHVS.US) With Buy Rating, Maintains Target Price $60
- Pharvaris (PHVS) Gets a Buy From H.C. Wainwright
- Form 144 | Pharvaris(PHVS.US) Officer Proposes to Sell 3.5 Million in Common Stocks
- A Quick Look at Today's Ratings for Pharvaris(PHVS.US), With a Forecast Between $44 to $79
- JonesTrading Maintains Pharvaris(PHVS.US) With Buy Rating, Maintains Target Price $52
- A Quick Look at Today's Ratings for Pharvaris(PHVS.US), With a Forecast Between $38 to $55
- BofA Securities Maintains Pharvaris(PHVS.US) With Hold Rating, Raises Target Price to $35 正面
- Wells Fargo Initiates Pharvaris(PHVS.US) With Buy Rating, Announces Target Price $55
- Morgan Stanley Maintains Pharvaris(PHVS.US) With Buy Rating, Raises Target Price to $46 正面
- Morgan Stanley Maintains Pharvaris(PHVS.US) With Buy Rating, Maintains Target Price $41
- Morgan Stanley Maintains Pharvaris(PHVS.US) With Buy Rating, Cuts Target Price to $30.4 负面
- BofA Securities Maintains Pharvaris(PHVS.US) With Hold Rating, Raises Target Price to $33 正面
- A Quick Look at Today's Ratings for Pharvaris(PHVS.US), With a Forecast Between $46 to $74
暂无评论——快来第一个聊聊 PHVS。